DSIP vs Epithalon: Two Small Peptides, Two Unresolved Literatures

The short answer

DSIP (delta sleep-inducing peptide) is a nine-amino-acid peptide first isolated in 1977 from the blood of rabbits during electrically induced sleep. Epithalon (also spelled epitalon) is a synthetic four-amino-acid peptide, Ala-Glu-Asp-Gly, designed to reproduce the activity attributed to epithalamin, an extract of the pineal gland. Both are studied in sleep, circadian and ageing-related research, but by different routes.

DSIP: a peptide still looking for its mechanism

DSIP was named for the sleep pattern associated with its discovery. Decades later, reviews still describe it as an unresolved riddle: no specific receptor or gene for it has been firmly established, and human sleep studies have been small with mixed results. Later work has also examined it in stress-response research.

Epithalon: a designed tetrapeptide

Epithalon was designed rather than discovered. Most of its published literature comes from one research tradition in St Petersburg, and recent cell-line work has studied its relationship to telomerase and telomere length. Claims about it in circulation often run ahead of what that record supports.

Evidence quality

Neither compound has a substantial modern human trial record or an established receptor. For both, the most useful thing a research design can do is state the evidence level plainly and regard the compound as an early-stage tool.